CAC
PTCT icon

Cowen and Company’s PTC Therapeutics PTCT Stock Holding History

Cowen and Company’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,590,655
Closed -$133M – 232
2024
Q3 		$133M Sell
3,590,655
-165,814
-4% -$5.55M 4.49% 6
2024
Q2 		$115M Buy
3,756,469
+30,843
+0.8% +$999K 3.16% 8
2024
Q1 		$108M Hold
3,725,626
– – 4.2% 5
2023
Q4 		$103M Buy
3,725,626
+2,926,115
+366% +$66.9M 6.73% 2
2023
Q3 		$17.9M Hold
799,511
– – 1.25% 20
2023
Q2 		$32.5M Buy
+799,511
New +$39.1M 2.7% 9

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cowen and Company's PTCT Position: Q4 2024 in Review

Cowen and Company sold out of PTC Therapeutics (PTCT) in Q4 2024, closing a stake of 3,590,655 shares — an estimated $133M sold.

Cowen and Company first reported a position in PTCT in Q2 2023 and held it in 6 quarters. The position peaked at $133M in Q3 2024. 239 funds tracked by Wall St. Rank hold PTCT as of Q4 2024.

  • Cowen and Company reported no remaining PTC Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 3,590,655 PTC Therapeutics shares in Q4 2024, an estimated $133M.
  • Cowen and Company first reported a position in PTC Therapeutics in Q2 2023 and held it in 6 quarters.
  • Cowen and Company's PTC Therapeutics position peaked at $133M in Q3 2024.
  • 239 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.